Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COAGULATION FACTOR IX RECOMBINANT HUMAN vs COBIMETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

COAGULATION FACTOR IX RECOMBINANT HUMAN vs COBIMETINIB: Safety Overview

Metric COAGULATION FACTOR IX RECOMBINANT HUMAN COBIMETINIB
Total FAERS Reports 1,066 4,071
Deaths Reported 20 527
Death Rate 1.9% 12.9%
Hospitalizations 167 1,895
Average Patient Age 27.7 yrs 59.3 yrs
% Female Patients 1.3% 47.4%
FDA Approval Date N/A Nov 10, 2015
Manufacturer N/A Genentech, Inc.
Route N/A ORAL
Marketing Status N/A Prescription